---
category: news
title: "Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies"
excerpt: "Dyno Tx Enters Collaboration and License Agreement with Roche to Develop Next-Gen AAV Gene Therapy Vectors for CNS Diseases, Liver-Directed Therapies"
publishedDateTime: 2020-10-15T03:05:00Z
originalUrl: "https://www.businesswire.com/news/home/20201014005248/en/Dyno-Therapeutics-Enters-Collaboration-and-License-Agreement-With-Roche-to-Develop-Next-Generation-AAV-Gene-Therapy-Vectors-for-CNS-Diseases-and-Liver-Directed-Therapies"
webUrl: "https://www.businesswire.com/news/home/20201014005248/en/Dyno-Therapeutics-Enters-Collaboration-and-License-Agreement-With-Roche-to-Develop-Next-Generation-AAV-Gene-Therapy-Vectors-for-CNS-Diseases-and-Liver-Directed-Therapies"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mms.businesswire.com/media/20201014005248/en/790645/23/Dyno-Logo-Final-050820.jpg"
    width: 1200
    height: 627
    isCached: true

secured: "YmGaBbANOP9oFBGAScMbJm9Gs3spw5xhu/Y6ltjEX5wm0t0nRI2Jx7JdwY+uSxRo3r7h0cln8WpkukYjxvY7PdDV7oaD5vu1sMMqcbdwfnqv+GY2kCcnw/9Wg37V+gtU4fexA71lzQB1PMTgvNB8MGpPHZjd5uyTSlE/UwBPmDCM28avv+Jq2NLVP+19M4jqASqJ5LLimLw2wBVwKgbqJ6UMSxJXCSz82wd5R/C/y7fOnhHYShysilY1SkF87Rn/RDT3ZIWQlzFIH8Jbw7765KLwrNOo2q5VSgLMQvOyh1aMjTQmiw+Cap0fvdzr/PVAqnEzzh9IBO6/1GVAtCAvA0Jcft/ERY2gdTF2gr/woSg=;E7YmE0B5qj/2gb/XLN3z8g=="
---

